Associations of antiplatelet therapy and beta blockade with patient outcomes in atherosclerotic renovascular disease
详细信息 查看全文
- 作者：James Ritchie ; PhD ; Darren Green ; PhD ; Helen V. Alderson ; MB ChB ; Constantina Chrysochou ; PhD ; Diana Vassallo ; MB ChB ; Smeeta Sinha ; PhD ; Philip A. Kalra ; MD ; Philip.kalra@srft.nhs.uk" class="auth_mail" title="E-mail the corresponding author
- 关键词：Aspirin ; beta blocker ; mortality ; renal artery stenosis
- 刊名：Journal of the American Society of Hypertension
- 出版年：2016
- 出版时间：February 2016
- 年：2016
- 卷：10
- 期：2
- 页码：149-158.e3
- 全文大小：746 K
文摘
- class="listitem" id="list_ulist0010">
- class="label">•
Few studies exist to define optimal medical therapy in patients with atherosclerotic renovascular disease.
- class="label">•
Antiplatelet use may be associated with a reduced risk for all-cause mortality.
- class="label">•
Beta blocker use may be associated with a reduced risk for all-cause mortality.
- class="label">•
Beta blocker use may be associated with a reduced risk for cardiovascular events.